"Dude, your stops are too tight. You drive me crazy."
That's Strazza, live, this morning, after I mentioned I'd been stopped out of Twist a couple weeks back.
We were going through a biotech relative strength scan and he asked what everyone's favorite was. JC said he's in PGEN and it's paying him. I mentioned I'd gotten shaken out of Twist Biosciences (TWST).
Then I got a scolding from Strazza. He told me to follow the primary trend and pointed out that Twist is one of the greatest biotech stories out there. Considering the stock is at a 5-year high today, it’s hard to argue against that.
He wasn't being mean. He was making a real point about knowing the characteristics of a given stock. If TWST is good enough for the Baker Bros, the greatest biotech investors we know of, then it should be good enough for me.
Getting stopped out because I’m impatient is not good risk management, and I need to work on that.
Strazza's approach to building a biotech basket is the opposite of how I'd do it, too. "Less is not more when you're building a biotech basket. More is truly more." Buy the leaders, and when one gaps down and stops you out, cut it and replace it with another name showing relative strength.
The basket is built to survive the ones that fail.
Getting corrected on air is not my favorite way to learn something, but it does tend to stick.
Questions and answers
#From the August 6, 2026 Daily Rundown.
What did Spencer learn from being stopped out of Twist Biosciences?
He questioned whether his stop reflected the stock's characteristics and primary trend or simply his own impatience. Strazza's criticism prompted him to reconsider that fit. The lesson was to align risk management with the setup, not to abandon exits whenever a stopped-out stock later rises.
How did Strazza describe managing failures within a biotech basket?
He favored owning a broader collection of leaders, then cutting a name that failed and replacing it with another showing relative strength. The basket was intended to accommodate individual failures. It still required managing those positions rather than assuming diversification made each holding safe.
Originally published by Spencer Israel.